SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

US Cancer Clinics Scramble to Get Experimental Revolution Medicines Pancreatic Cancer Drug

U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await...

Implanted Islet Cell Device Could Control Glucose for Weeks

Researchers developed a battery-free device the size of a coin that can deliver islet cells in the body and keep them healthy, no immunosuppression required.

Blame for the Obesity Epidemic Falls on Food Industry

The rise of new weight-loss drugs could help reframe obesity as a societal failure driven by the food industry, rather than an individual failing rooted in lack of willpower.

Can GLP-1 Drugs Improve Breast Cancer Survival?

A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are unconvinced.

EyePoint's Late-stage Eye Drug Trials to Continue After Safety Panel Review

EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials ⁠of its experimental eye disease drug Duravyu and recommended the...

Can Gut Bacterium Supplement Lead to Less Weight Regain?

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await...

Researchers developed a battery-free device the size of a coin that can deliver islet cells in the body and keep them healthy, no immunosuppression required.

The rise of new weight-loss drugs could help reframe obesity as a societal failure driven by the food industry, rather than an individual failing rooted in lack of willpower.

A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are unconvinced.

EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials ⁠of its experimental eye disease drug Duravyu and recommended the...

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

News All Time

Hidden Sugar Traps Patients With Diabetes Should Recognize

Food labels are often misleading when it comes to glycemic impacts.

Oral Orforglipron Effective in Older Adults With Obesity

People over 65 taking once-daily oral orforglipron achieved substantial weight loss with a consistent safety profile, regardless of T2D status, in a post hoc ATTAIN trial analysis.

Refining Management Strategies for Patients With Endometriosis

Refining Management Strategies for Patients With Endometriosis

Toddler Has Menstrual Cycle at 17 Months

Clinicians ruled out precocious puberty before landing on a diagnosis of exclusion

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Accurate and Timely Diagnosis of Endometriosis

Accurate and Timely Diagnosis of Endometriosis

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Many Older Patients Can Ditch Common Thyroid Drug, Study Suggests

Experts call for better guidance on levothyroxine initiation, deprescribing

GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics

News and commentary from the endocrinology world

Further Doubt on Heart-Healthiness of Calcium Supplements

Recurrent cardiovascular events increased in a large cohort study

Drug Manufacturer Coupon Use; Cholesterol Targets for Secondary Prevention

Also in TTHealthWatch: deprescribing levothyroxine

Are GLP-1 Drugs Linked to Erectile Dysfunction?

Real-world study in type 2 diabetes suggests possible association, but more research is needed

Call to Integrate Obesity Management With Surgery, GLP-1s Into Cancer Care

"Most effective therapies" underutilized, say authors, but oncologist cites lack of quality data

Recommended News For You

Dual-action mRNA vaccine takes aim at aggressive skin cancer

Drop in credit score after cancer diagnosis linked to increased mortality

10-year study shows tomosynthesis improves breast cancer detection

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

Recommended Articles For You

Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment 

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies 

Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies 

Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

2.

Photopenia on [18F]FDG PET/CT Predicts Benign Renal Lesions

3.

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

4.

When a Groundbreaking Cancer Therapy Causes Cancer.

5.

Study sheds light on challenges for women of color after breast cancer surgery

1.

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies

2.

What You Need to Know About the Early Warning Signs of Colon Cancer 

3.

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches

4.

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide

5.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

3.

Efficient Management of First line ALK-rearranged NSCLC

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot